Royal Bank Of Canada Amicus Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 216,584 shares of FOLD stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

216,584

Previous 288,037 24.81%

Holding current value

$2.06 Million

Previous $2.86 Million 19.04%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $682,376 - $863,866	-71,453 Reduced 24.81%	216,584 $2.31 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $274,906 - $357,317	30,410 Added 11.8%	288,037 $2.86 Million
Q1 2024 Nov 05, 2024	SELL	$11.43 - $14.24 $347,586 - $433,038	-30,410 Reduced 10.56%	257,627 $3.03 Million
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $942,346 - $1.17 Million	-82,445 Reduced 24.24%	257,627 $3.03 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $565,019 - $822,877	56,672 Added 20.0%	340,072 $4.83 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $367,842 - $432,792	31,226 Added 12.38%	283,400 $3.45 Million
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $128,940 - $159,972	-12,028 Reduced 4.55%	252,174 $3.17 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $230,561 - $286,140	-21,133 Reduced 7.41%	264,202 $2.93 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $899,683 - $1.16 Million	90,969 Added 46.8%	285,335 $3.48 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $54,834 - $71,196	5,584 Added 2.96%	194,366 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $25,000 - $44,624	4,013 Added 2.17%	188,782 $2.03 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $152,568 - $241,325	-19,337 Reduced 9.47%	184,769 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $450,531 - $570,734	45,879 Added 29.0%	204,106 $2.36 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $101,882 - $138,018	11,657 Added 7.95%	158,227 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $1.28 Million - $1.57 Million	146,570 New	146,570 $1.41 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Amicus Therapeutics, Inc. Transaction History